Greif J - Search Results

1

Suppressor cell activity of human alveolar macrophages in interstitial lung diseases.

Fireman EM, Ben Efraim S, Greif J, Kivity S, Topilsky MR. Fireman EM, et al. Among authors: greif j. Clin Exp Immunol. 1988 Jul;73(1):111-6. Clin Exp Immunol. 1988. PMID: 2971484 Free PMC article.

2

Effect of montelukast, a cysteinyl receptor antagonist, on myofibroblasts in interstitial lung disease.

Fireman E, Schwartz Y, Mann A, Greif J. Fireman E, et al. Among authors: greif j. J Clin Immunol. 2004 Jul;24(4):418-25. doi: 10.1023/B:JOCI.0000029110.11097.4d. J Clin Immunol. 2004. PMID: 15163898

3

Suppressive activity of alveolar macrophages and blood monocytes from interstitial lung diseases: role of released soluble factors.

Fireman E, Ben Efraim S, Greif J, Alguetti A, Ayalon D, Topilsky M. Fireman E, et al. Among authors: greif j. Int J Immunopharmacol. 1989;11(7):751-60. doi: 10.1016/0192-0561(89)90129-x. Int J Immunopharmacol. 1989. PMID: 2557288

4

Correlation between PGE2 production and suppressor activity of alveolar macrophages from patients with interstitial lung diseases.

Fireman E, Ben Efraim S, Greif J, Alguetti A, Ayalon D, Topilsky M. Fireman E, et al. Among authors: greif j. Immunol Lett. 1988 Jun;18(2):159-65. doi: 10.1016/0165-2478(88)90058-2. Immunol Lett. 1988. PMID: 3165369

5

Suppressive mechanisms of alveolar macrophages in interstitial lung diseases: role of soluble factors and cell-to-cell contact.

Fireman E, Ben-Efraim S, Spinrad S, Topilsky M, Greif J. Fireman E, et al. Among authors: greif j. Eur Respir J. 1993 Jul;6(7):956-64. Eur Respir J. 1993. PMID: 8370444

6

Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis.

Fireman E, Vardinon N, Burke M, Spizer S, Levin S, Endler A, Stav D, Topilsky M, Mann A, Schwarz Y, Kivity S, Greif J. Fireman E, et al. Among authors: greif j. Eur Respir J. 1998 Mar;11(3):706-11. Eur Respir J. 1998. PMID: 9596125 Free article.

7

Induced sputum compared to bronchoalveolar lavage for evaluating patients with sarcoidosis and non-granulomatous interstitial lung disease.

Fireman E, Topilsky I, Greif J, Lerman Y, Schwarz Y, Man A, Topilsky M. Fireman E, et al. Among authors: greif j. Respir Med. 1999 Nov;93(11):827-34. doi: 10.1016/s0954-6111(99)90269-x. Respir Med. 1999. PMID: 10603633 Free article. Clinical Trial.

8

Induced sputum-retrieved matrix metalloproteinase 9 and tissue metalloproteinase inhibitor 1 in granulomatous diseases.

Fireman E, Kraiem Z, Sade O, Greif J, Fireman Z. Fireman E, et al. Among authors: greif j. Clin Exp Immunol. 2002 Nov;130(2):331-7. doi: 10.1046/j.1365-2249.2002.t01-1-02001.x. Clin Exp Immunol. 2002. PMID: 12390324 Free PMC article.

9

Differential Proliferative Characteristics of Alveolar Fibroblasts in Interstitial Lung Diseases: Regulative Role of IL-1 and PGE(2).

Fireman E, Ben Efraim S, Greif J, Peretz H, Kivity S, Topilsky M, Rodrig Y, Yellin A, Apte RN. Fireman E, et al. Among authors: greif j. Mediators Inflamm. 1994;3(6):445-52. doi: 10.1155/S0962935194000633. Mediators Inflamm. 1994. PMID: 18475594 Free PMC article.

10

Cell-free supernatants of sarcoid alveolar macrophages suppress proliferation of sarcoid alveolar fibroblasts.

Fireman E, Ben Efraim S, Messer G, Dabush S, Greif J, Topilsky M. Fireman E, et al. Among authors: greif j. Clin Immunol Immunopathol. 1991 Jun;59(3):368-78. doi: 10.1016/0090-1229(91)90032-6. Clin Immunol Immunopathol. 1991. PMID: 2029791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters